Clinical Trial Update: Benefit of Clarithromycin in Patients With Severe Infections Through Modulation of the Immune System [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating clarithromycin for severe infections by modulating the immune system in sepsis and pneumonia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia
• Sepsis

Drugs mentioned

• clarithromycin (clarithromycin)

Snippet

Sponsor: Hellenic Institute for the Study of Sepsis | Conditions: Sepsis, Pneumonia | Phase 3 | Status: COMPLETED